OOIR: Observatory of International Research

Papers

(The median citation count of Critical Reviews in Microbiology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	76
TREM-2: friend or foe in infectious diseases?	74
Salmonella in eggs and egg-laying chickens: pathways to effective control	64
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	49
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	48
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	46
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	41
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	40
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	36
Current and emerging therapies for fungal biofilms and systemic infections	35
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	34
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	33
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	33
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses	29
LysR-type transcriptional regulators: state of the art	28
Exploring halophilic environments as a source of new antibiotics	28
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	27
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	26
Helicobacter pylori ’s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread	25
Vibrio cholerae virulence and its suppression through the quorum-sensing system	24
The microbiome and precision oncology: an emerging paradigm in anticancer therapy	24
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	24
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties	23
Polyamine as a microenvironment factor in resistance to antibiotics	23

Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	23
Bacterial vaginosis: advancing insights into microbial dysbiosis	22
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	20
The diffusible signaling factor family in microbial signaling: a current perspective	20
Building up a clinical microbiota profiling: a quality framework proposal	19
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	18
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	17
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	17
Biotherapeutic potential of gut microbiota-derived indole-3-acetic acid	17
Phage-bacterial evolutionary interactions: experimental models and complications	17
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	16
Microbial persisters and host: recent advances and future perspectives	16
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	15
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	15
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	14
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	14
Advances in mining and expressing microbial biosynthetic gene clusters	14
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	13
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	13
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	13
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	13
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	13
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	12
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	12
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	12
Aspergilli series Versicolores: importance of species identification in the clinical setting	12
Genetic basis of antibiotic resistance in bovine mastitis and its possible implications for human and ecological health	11
Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa	11
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects	11
The crosstalk between SUMOylation and immune system in host-pathogen interactions	11
Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans	11
Anti-virulence peptides: a compromising strategy to treat Staphylococcus aureus chronic wound infection	11
Antibiotic resistance genes in Escherichia coli – literature review	11
Marine microbial enzymes as potential antibiofilm agents: expanding the arsenal of bioactive agents targeting biofilm-forming microorganisms	10
The final gate: bacterial subversion of autophagosome-lysosome fusion as a conserved immune evasion strategy	10
Unravelling the sponge microbiome as a promising source of biosurfactants	10
Ex vivo challenge models for infectious diseases	10
Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia	10
Phage-inspired strategies to combat antibacterial resistance	10
Type IV pilin regulation: a transcriptional overview	10
Multiple potential strategies for the application of nisin and derivatives	9
Mycobacterium avium biofilms: mechanism of production, composition, and its role in pathogenesis and drug resistance	9
Microparticles and nanoparticles-based approaches to improve oral treatment of Helicobacter pylori infection	9
The high osmolarity glycerol (HOG) pathway in fungi^†	9
Towards the discovery of novel molecular clocks in Prokaryotes	9
Acinetobacter baumannii subunit vaccines: recent progress and challenges	8
The therapeutic potential of phage-based antifungal treatment: strategies, mechanisms, and prospects	8
The complement system as a key modulator of the oral microbiome in health and disease	8
Thermogenesis dynamics and influenza A virus: unveiling the intriguing interplay	8
Molecular imaging of bacterial biofilms—a systematic review	8

Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings	8
Are anaerobic fungi crucial hidden players of microbiomes in anoxic environment?	8
Interactions between the foreign body reaction andStaphylococcus aureusbiomaterial-associated infection. Winning strategies in the derby on biomaterial implant surfaces	8
Peeling off the layers from microbial dark matter (MDM): recent advances, future challenges, and opportunities	8
Virovory: control of viral pathogenesis by the protists and the way forward	8
Peptide-based strategies for overcoming biofilm-associated infections: a comprehensive review	8
Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases	8
Blocking horizontal transfer of antibiotic resistance genes: an effective strategy in combating antibiotic resistance	7
Biofilm-associated Escherichia coli infections: pathogenesis, clinical implications, and treatment strategies	7
Regulatory transcription factors of Clostridioides difficile pathogenesis with a focus on toxin regulation	7
A comprehensive review of Bifidobacterium spp : as a probiotic, application in the food and therapeutic, and forthcoming trends	7
Macrophage biology in the pathogenesis of Helicobacter pylori infection	7
Glycosylation orchestrates virulence and pathogenicity of periodontal keystone pathogens	7
Biosensors for the detection ofMycobacterium tuberculosis: a comprehensive overview	7
Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review	7
Recent advances in understanding of multifaceted changes in the vaginal microenvironment: implications in vaginal health and therapeutics	6
Selective pressures for public antibiotic resistance	6
Activation of host nucleic acid sensors by Mycobacterium : good for us or good for them?	6
The development and application of the Environmental Relative Moldiness Index (ERMI)	6
Water and mosquitoes as key components of the infective cycle of Francisella tularensis in Europe: a review	6
Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes	6
Polymicrobial biofilms related to dental implant diseases: unravelling the critical role of extracellular biofilm matrix	6
A multifarious bacterial surface display: potential platform for biotechnological applications	6
The search for aliens within us: a review of evidence and theory regarding the foetal microbiome	6
The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy	5
The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung	5
The WxxxE proteins in microbial pathogenesis	5
Bile acid and its bidirectional interactions with gut microbiota: a review	5
Applications of the phage display technology in molecular biology, biotechnology and medicine	5
Botanicals as promising antimicrobial agents for enhancing oral health: a comprehensive review	5
Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis	5
The role of bacteriophage in inflammatory bowel disease and its therapeutic potential	5
Evaluation of the antifungal effect of plant extracts on oral Candida spp. – a critical methodological analysis of the last decade	5
Current developments and prospects of the antibiotic delivery systems	5
Interplay between lipid metabolism, lipid droplets and RNA virus replication	5